Dipeptidyl peptidase inhibitors

Details for Australian Patent Application No. 2004318013 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Gwaltney, Stephen L.; Salisbury, Jonathon; Palmer, Grant; Elder, Bruce; Stafford, Jeffrey A.; Ulysse, Luckner; Zhang, Zhiyuan; Feng, Jun; Ibster, Paul

Agent Griffith Hack

Pub. Number AU-B-2004318013

PCT Pub. Number WO2005/095381

Priority 60/553,571 15.03.04 US; 60/629,524 18.11.04 US

Filing date 15 December 2004

Wipo publication date 13 October 2005

Acceptance publication date 8 September 2011

International Classifications

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 39/02 (2006.01) General protective or antinoxious agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 239/545 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/553 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095381 Priority application(s): WO2005/095381

8 September 2011 Application Accepted

  Published as AU-B-2004318013

6 October 2011 Corrigenda

  Applications Accepted - Name Index Under the name Takeda Pharmaceutical Company Limited, Application No. 2004318013 under INID (72) correct the co-inventor to Salsbury, Jonathon; under INID (72) correct the coinventor to Isbester, Paul

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004318024-Method and device for introducing heading supports

2004318012-Method of converting C9 aromatics - comprising mixtures to xylene isomers